Bergabunglah dengan Buletin Kami
Bergabunglah dengan daftar pelanggan kami untuk mendapatkan artikel terkini, update dan penawaran khusus langsung di kotak masuk Anda
Launch follows CDSCO marketing authorisation for disease-modifying therapy ind...
IPO comprises an offer for sale by promoters and investor selling shareholder t...
S Swaminathan, CEO, GS1 India explains to Express Pharma the broader benefits o...
India's Foremost Pharma & Biotech Magazine ~ Power, Politics And Pharma The pos...
The partnership is intended to jointly advance methods that address one of the m...
The investment will support the expansion of Resilience’s advanced manufacturing...
The Society of Clinical Research and Medical Professionals (SCRMP) will host SC...
India is building a future-ready drug regulatory framework to accelerate health...
Global pharma major Lupin announced that following approval from the United Sta...
Amgen announced the launch of the first Amgen Scholars Program in India at the ...
Arboreal Bioinnovations, India’s first specialty food and nutraceutical ingredi...
SMRT Architects & Engineers recently announced Principal Rebecca Casey, AIA, as ...
The companies will become 100%-owned subsidiaries of Caldera Therapeutics, a new...
Repatha is intended for adults with established or high risk of atherosclerotic ...
The two-day conference brought together leading oncologists, clinicians, public...
Aesthetic medicine is no longer a boutique corner of healthcare. The Internatio...